Optimizing Platelet Isolation (The Cell Study)

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

16 participants

Study Classification

OBSERVATIONAL

Study Start Date

2020-07-06

Study Completion Date

2021-01-25

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The research study is about blood cells (platelets) and their power houses (mitochondria). The investigators want to learn about their behavior in order to ensure that our laboratory procedures are generating optimal results.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Platelet Volunteers, Longitudinal and Multi-omic Study

NCT07137429

Thrombosis

RECRUITING

Unravelling the Role of Apoptosis in Platelets Biogenesis Through the Study of the Thrombocytopenia THC4

NCT07026578

Thrombocytopenia, Isolated Thrombocytopenia 4 CYCS MUTATION- ASSOCIATED THROMBOCYTOPENIA THC4

ACTIVE_NOT_RECRUITING

Evaluating the Safety of Long Term Dosing of Romiplostim (Formerly AMG 531) in Thrombocytopenic Subjects With Myelodysplastic Syndromes (MDS)

NCT00472290

Hematology MDS Myelodysplastic Syndromes +1 more

COMPLETED NA

Evaluation of Whole Blood With CPD Anticoagulant and AS-7/SOLX Additive Solution

NCT02145507

Blood Donors

COMPLETED PHASE1

Effect of Eltrombopag Plus G-CSF on Human CD34+ Cell Mobilization in Multiple Myeloma Patients Undergoing ASCT

NCT01286675

Multiple Myeloma

COMPLETED EARLY_PHASE1

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The objectives of this study are to assess platelet activation following standard laboratory procedures used in the process of measuring platelet mitochondrial function, and to determine the optimal amount of digitonin needed to permeabilize platelet cell membrane.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Healthy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age 25-35
* All races
* All ethnicity
* 18.5 - 30 BMI

Exclusion Criteria

* smoking
* Aspirin intake
* Recreational drug use
* Alcohol intake more than 3 times per week
* Self-reported possibility of current pregnancy
* Known diagnosis of:
* Pre-diabetes
* Diabetes
* High cholesterol
* High triglycerides
* Hypertension
* Anemia
* Autism spectrum disorder
* Attention deficit hyperactivity disorder (ADHD)
* Attention deficit disorder (ADD)
* Severe asthma
* Refusal to stop taking nutritional supplements
* Any other pre-existing medical condition that requires daily medication as determined by the investigators to affect outcome of interest

Minimum Eligible Age

25 Years

Maximum Eligible Age

35 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes